Dual Inhibition of SRC Family Kinases and Sorafenib Enhances Anti-Tumor Activity in Hepatocellular Carcinoma Cells. - Cabral LK; Disoma C; Tarchi P; El-Khobar KE; Agustiningsih A; Dituri F; Tiribelli C; Sukowati C (International journal of molecular sciences, 2025)